
Conference: ISSX 2025 International Meeting
開催日: September 12 - 14, 2025
エリア:Chicago, Illinois
Get an exclusive preview of DIDB’s ConMed Navigator
Built on regulatory agency-recommended classifications and powered by DIDB data, ConMed Navigator is scheduled to launch in Fall 2025. Sign up for a product demo to learn about how CoMed Navigator helps scientists to quickly identify concomitant medications.
Where to hear Certara insights and expertise
Co-chairs: Jaydeep Yadav, Merck; Fei Hua, Certara; Vivaswath Ayyar, GSK
- FIH dose predictions for protein degraders with PKPD modelling – Jaydeep Yadav, Merck
- Translational strategies for multi-specific antibodies (t-cell engagers) in oncology/immunology – Fei Hua, Certara
- Modelling of oligonucleotides and RNAi therapeutics – Vivaswath Ayyar, GSK
Poster presentation
Presenting Author: Jingjing Yu, Director, Drug Interaction Solutions
Co-Author(s): Sophie Argon, Katie Owens, Yan Wang, Isabelle Ragueneau-Majlessi
In the present work, drug metabolism, drug transport, and drug interaction in vitro, in silico, and clinical data for small molecular drugs approved by the U.S. Food and Drug Administration in 2024 (N = 34) were analyzed using Certara Drug Interaction Database (DIDB®)
デモのご予約または無料トライアルのお申し込み
DIDB®が貴社の医薬品開発プロセスをどのように変革できるかをご覧ください。お気軽にデモをご予約いただくか、無料トライアルをお申し込みいただき、高度な機能と性能をご体験ください。